How The Transfemoral Tavr Procedure Is Performed?

Transfemoral TAVR is a procedure where a replacement heart valve is threaded through an artery in the groin and guided up to the heart, so the chest does not need to be opened. The full name is transcatheter aortic valve replacement. “Transfemoral” refers to the transfemoral artery, the large blood vessel in the upper leg. A small incision is made near the groin, a thin tube called a catheter is inserted, and the new valve is moved into position inside the diseased aortic valve. Once it is in place, a balloon or a self-expanding frame opens the valve and holds it there. The old valve is not removed — it is pushed aside and the new valve takes over its job.

What Is TAVR and Why Is It Done?

The aortic valve sits between the heart’s left ventricle and the aorta, the main artery leaving the heart. When it narrows — a condition called aortic stenosis — the heart has to work much harder to push blood out. Over time this can cause shortness of breath, chest pain, fainting, and heart failure.

For decades, the standard fix was surgical aortic valve replacement (SAVR), which requires opening the chest and stopping the heart temporarily. TAVR was developed as a less invasive option. Instead of opening the chest, doctors reach the valve through a blood vessel.

TAVR is now used across a wide range of patients. It was first reserved for people too frail or too sick for open-heart surgery. Over time, trials in lower-risk patients showed results that were broadly comparable to surgery for many of them. Because the field has moved quickly, current guidelines on who should get TAVR versus surgery are worth checking with a heart team rather than assuming one approach is always better.

How The Transfemoral TAVR Procedure Is Performed

The transfemoral route is the most common way TAVR is done. Here is the general sequence.

• The patient is usually given general anesthesia or deep sedation, depending on the team and the patient.
• A small incision is made in the groin, and the femoral artery is accessed.
• A sheath is placed in the artery to keep it open during the procedure.
• A catheter carrying the collapsed replacement valve is advanced through the artery, up through the aorta, and into the heart.
• Imaging — typically echocardiography and fluoroscopy (real-time X-ray) — guides the valve into the aortic position.
• A balloon may be inflated to expand the valve, or the valve may open on its own using a self-expanding frame.
• The catheter is removed, the artery is closed, and the incision is sealed.

The whole procedure often takes one to two hours, though this varies. The patient usually stays in the hospital for a short period afterward. Most people are up and moving within a day or so, but recovery timelines differ from person to person and depend on overall health.

One detail that surprises many people: the old valve is not cut out. The new valve is expanded inside it, pressing the old leaflets against the wall of the aorta. The new valve then controls blood flow.

What Happens Before the Procedure?

Before a transfemoral TAVR, the heart team does a full workup. This usually includes:

• Echocardiography to measure how narrow the valve is and how well the heart is pumping.
• CT angiography to map the arteries, measure the valve opening, and plan the valve size.
• Blood tests, an electrocardiogram, and sometimes a coronary angiogram.
• A review of kidney function, lung function, and other conditions.

The CT scan is especially important. It shows whether the femoral arteries are wide enough and free of too much plaque to allow the catheter through. If the arteries are too narrow or too diseased, the team may choose a different access route — such as through the chest wall or the neck — instead of the groin.

How Is Transfemoral Different From Other TAVR Approaches?

TAVR can be done through several access points. The transfemoral route is the least invasive and is generally preferred when the arteries allow it.

The choice depends on the patient’s anatomy, prior surgeries, and the team’s experience. Transfemoral is generally associated with faster recovery than the other routes, but it is not always an option.

What Are the Risks and Complications?

TAVR is a major procedure, and like any procedure it carries risks. The evidence on complication rates comes from large trials and registries, and rates vary by patient and center.

Known risks include:

• Stroke — a small but real risk during and after the procedure.
• Bleeding or damage at the groin access site.
• Problems with the heart’s electrical system, sometimes requiring a permanent pacemaker.
• Kidney injury from contrast dye used in imaging.
• Leaking around the new valve (called paravalvular leak).
• Infection, blood clots, or reactions to anesthesia.

The risk of stroke is one reason TAVR teams use careful imaging and sometimes embolic protection devices during the procedure. Some studies suggest these devices can reduce certain types of stroke, but the evidence on whether they improve overall outcomes is still developing.

Paravalvular leak — blood leaking around the outside of the new valve — was more common with early valve designs. Newer valves have reduced this, but it has not been eliminated. The significance of a small leak is not always clear and is monitored over time.

How Long Does Recovery Take?

Recovery after transfemoral TAVR is often faster than after open-heart surgery. Many patients spend a night or two in the hospital, though this varies. Some go home within a day or two. Others need longer, depending on their health before the procedure.

In the first few days, people are usually advised to avoid heavy lifting and to keep the groin site clean and dry. Light activity is often encouraged. Full recovery — meaning a return to normal energy and activity — can take several weeks. This timeline is general; individual recovery depends on age, other medical conditions, and how the heart was functioning before.

Follow-up visits are important. Doctors check the valve with echocardiography, monitor symptoms, and adjust medications as needed. The long-term durability of TAVR valves is an active area of study. Current evidence shows good function for many years, but because TAVR is newer than surgery, the very long-term data are still being collected.

Who Is a Candidate for Transfemoral TAVR?

TAVR is generally considered for people with severe aortic stenosis who have symptoms or whose heart is showing strain from the narrowed valve. The decision is made by a heart team — usually including a cardiologist, a cardiac surgeon, and imaging specialists.

Factors that favor transfemoral TAVR include:

• Femoral arteries that are wide enough and not too diseased.
• Anatomy that fits available valve sizes.
• High risk for open-heart surgery, or a preference to avoid it.

Factors that may make another approach better include severe peripheral artery disease, prior groin surgery, or certain anatomical features. Age alone is not the deciding factor. The heart team weighs the whole picture.

It is also worth knowing that not everyone with aortic stenosis needs a valve replacement right away. Mild or moderate narrowing may be monitored. Severe narrowing with symptoms usually needs treatment, but the timing and type are individual decisions. No clinical guideline supports delaying a needed valve replacement based on symptoms alone without medical input.